Deep Apple Therapeutics logo

Deep Apple Therapeutics

Accelerating drug discovery with structure-based large library virtual screening and deep learning models

27 employees · est. 2022 · United States

VS
Kuano logo

Kuano

Providing innovative quantum and AI solutions for drug discovery and design.

19 employees · est. 2020 · London, United Kingdom

Kuano is the older company (2022 vs 2020).

Side-by-Side Comparison

Deep Apple Therapeutics Kuano
Founded
2022 2020 older
Headquarters
United States London, United Kingdom
Employees
27 19
Industry
Biotechnology, Health and Wellness AI, Biotechnology
Funding Stage
Series A Seed
Total Funding
$52.00M $2.80M
Funding Rounds
1 4
Services
Deep learning drug discovery engine, Virtual screening of chemical libraries, Structural biology and molecular modeling In-silico Drug Design with Quantum and AI, Medicinal Chemistry Expertise
Target Customers
Pharmaceutical companies, Biotechnology firms, Research institutions Pharmaceutical Companies, Biotech Startups, Research Institutions
Taxonomy
Drug Discovery, Structure-Based Drug Design, Deep Learning, Virtual Screening, Cryo-EM Technology, Ensemble Cryo-EM, Protein Dynamics, Molecular Docking, Computational Modeling, Chemical Space Exploration, Target Structure Determination, Metabolic Diseases, Endocrine Diseases, Inflammatory Diseases Drug Discovery, Quantum Computing, Enzyme Inhibitors, Collaborations, Academic Partnerships, Quantum Mapping, AI-Led Chemistry, Targeted Drug Design, Innovative Solutions, Biotech Partnerships
Website
deepappletx.com kuano.ai
Deep Apple Therapeutics logo

About Deep Apple Therapeutics

Deep Apple Therapeutics, founded in 2022, is a U.S.-based company in the Biotechnology and Health and Wellness industries. Their mission, as encapsulated by their slogan, is "Accelerating drug discovery with structure-based large library virtual screening and deep learning models." Their innovative...

Kuano logo

About Kuano

Kuano is a UK-based startup that specializes in providing innovative quantum and AI solutions for drug discovery and design. Their unique approach integrates target quantum mapping and AI-led chemistry to expedite the development of superior drug candidates. By employing Quantum Mapping of targets,...

We will tell you when either one moves

BounceWatch watches Deep Apple Therapeutics and Kuano for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Deep Apple Therapeutic... and Kuano — by email.

Frequently Asked Questions

Deep Apple Therapeutics — Accelerating drug discovery with structure-based large library virtual screening and deep learning models. Kuano — Providing innovative quantum and AI solutions for drug discovery and design.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Deep Apple Therapeutics has raised $52.00M while Kuano has raised $2.80M.
Deep Apple Therapeutics and Kuano operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Deep Apple Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Deep Apple Therapeutics on 15 Jun 2026, and Kuano on 1 Dec 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes